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Abstract A novel entirely in vitro strategy for generation and
screening of a combinatorial protein library in an array format
has been developed and is experimentally demonstrated. The
strategy exploits virtues of PCR and in vitro coupled transcrip-
tion/translation. Our new approach provides high-throughput
construction and screening of the in vitro protein library, and
compatibility with various selection methods.
! 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Several cell-based peptide display technologies for directed
evolution of protein have been developed and utilized practi-
cally in the past decade [1,2]. However, those display technol-
ogies have inherent limitations, particularly, on applications
with cytotoxic proteins and the achievable library size. A few
promising in vitro display technologies which could overcome
those limitations have been proposed and practically demon-
strated [3^5]. Inevitably, due to the fact that all prominent
protein display technologies are based on a⁄nity selection,
they are inapplicable to peptides or proteins without known
and suitable binding. In addition, maintaining the physical
genotype^phenotype linkage throughout the processes re-
quires laborious works on design and optimization.
With great merits of PCR [6^9] and cell-free protein syn-
thesis [10,11] we have recently developed a combination
of single-molecule DNA polymerase chain reaction ampli-
¢cation (SM-PCR) and in vitro coupled transcription/
translation, which has lately been termed SIMPLEX
(SingleMolecule PCR Linked in vitro Expression), for
high-throughput construction of a protein library that is com-
patible with various screening methods [12,13]. Brie£y, a gene
pool is prepared to use as templates for separated single-mol-
ecule DNA ampli¢cation. Every DNA template in the pool is
equipped with all components necessary for the in vitro
coupled transcription/translation (Fig. 2A). After the SM-
PCR, each PCR products are directly transcribed and trans-
lated in vitro yielding a protein library. Uniformities of
amounts of SM-PCR products and proteins produced by
the SIMPLEX which are vital for quantitative comparison
were experimentally con¢rmed [14]. Its practicability and ap-
plicability were successfully demonstrated [14,15]. Even
though the size of a protein library generated by the SIM-
PLEX would be ultimately unlimited, it is currently not prac-
tical at low cost. A miniaturized PCR system that could em-
power the SIMPLEX is not presently available. Therefore, the
achievable library size is inevitably constrained by the ca-
pacity of existing thermocyclers and requirement of costly
DNA polymerase. In this work, we describe a novel high-
throughput SIMPLEX-based strategy for construction and
screening of combinatorial protein libraries in an array format
with expanded capacity and increased cost-e¡ectiveness and
its practicability is demonstrated.
2. Materials and methods
2.1. Preparation of DNA templates with random mutation
Two single chain variable fragment (scFv) encoding genes with
random mutation (NNS NNS), i.e. anti-HSA-scFv with mutation at
G99-A100 of VH (Fig. 2B) and anti-HSA-scFv with mutation at Q90-
W91 of VL (Fig. 2C), were prepared by combination of conventional
PCR and overlapping PCR as previously reported [14]. The original
anti-HSA-scFv was from the pRSET-scFv. The DNA templates with
random mutation were puri¢ed and their concentrations were deter-
mined by measuring absorbance at 260 nm.
2.2. Multiplex-PCR and SM-PCR
The DNA templates were typically diluted with 0.1% (w/v) Blue
Dextran 2000 (Amersham-Pharmacia) in TE bu¡er to 1, 5 or 10
molecules per well (1.28U1039 ng of the DNA template was estimated
as one molecule). The ampli¢cation was carried out in a total volume
of 10 Wl with 0.5 U of the Pfu Turbo1 DNA polymerase (Stratagene),
0.125 mM of each dNTP, and 0.5 WM of a primer, which annealed to
both ends of the template, in the cloned Pfu bu¡er. The reaction
mixtures were pre-heated at 94‡C for 3 min, followed by 70 cycles
of: 5 s at 96‡C; 5 s at 55‡C; 1 min and 20 s at 72‡C. All PCRs were
carried out by the GeneAmp0 PCR system 9700 (PE Applied Bio-
systems).
2.3. Examination of equality of ampli¢cation
Five-molecule PCR products were cloned into the pT7Blue-3 blunt
vector (Novagen) and then electroporated into Escherichia coli
JM109. White colonies were randomly selected and subjected to col-
ony PCR using primers annealing to the vector (M13-RV-N and
M13-M1CC). Colony PCR products were treated with the PCR prod-
uct pre-sequencing kit (Amersham Pharmacia Biotech, Inc.) and se-
quenced using the Thermo Sequenase1 II dye terminator cycle se-
quencing premix kit (Amersham Pharmacia Biotech, Inc.). Clones
possessing each distinct sequence were counted.
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2.4. Anti-HSA-scFv(QW) library construction and screening
A pool of anti-HSA-scFv with random mutation at Q90-W91 of VL
was prepared as described above. Ten-molecule PCR was performed
in 96-well plates. The in vitro coupled transcription/translation of all
PCR products were carried out in 40 Wl reactions with components as
previously reported [14], also in 96-well plates. The reactions were
incubated at 30‡C for 90 min, subsequently put on ice to stop the
reaction. Control reactions were performed under the identical con-
dition without the DNA template.
The scFv library was screened by means of ELISA. Brie£y, 96-well
plates (Beckton Dickinson and Company) were coated with the hu-
man serum albumin (HSA) (Nakarai, Japan), and blocked by 3%
bovine serum albumin (Sigma). Each cell-free reaction mixture in
the protein library was diluted and added into the pre-coated plate.
Penta-His horseradish peroxidase (HRP) conjugate (Qiagen) was used
as a secondary antibody interacting with the histidine-tag of the anti-
HSA-scFv. Finally, orthophenylenediamine (Wako Pure Chemical In-
dustries, Japan) solution, a substrate for the enzyme HRP, was added
to each well. The enzymatic reaction was terminated by 2 M H2SO4
and ELISA signals were determined by measuring the absorbance at
492 nm by the SPECTRA MAX250 (Molecular Devices). PCR prod-
ucts of positive reactions were collected, puri¢ed and subsequently
used as templates for the next round of construction and screening,
where the SM-PCR is employed instead of the 10-molecule PCR.
Sequences of positive clones were analyzed.
3. Result
3.1. SIMPLEX-based library with expanded capacity
In order to increase the achievable size of the SIMPLEX-
based library, a PCR of multiple molecules of templates (e.g.
10 molecules), denoted multiplex-PCR, is implemented for an
initial construction of the library (Fig. 1). Compared with a
library generated by the SM-PCR, a library that is primarily
generated by 10-molecule PCR should have its size enlarged
10 times, providing that each molecule of templates is ampli-
¢ed equally. The primary PCR library is directly transformed
to a primary protein library by means of in vitro coupled
transcription/translation. Thereafter, the protein library is
screened. PCR products of positive reactions from the pri-
mary PCR library are collected and subjected to the next
round of construction and screening, where the SM-PCR is
employed in order to obtain every single positive clone.
3.2. Equality of ampli¢cation of each template in
a multiplex-PCR
According to our strategy, equal ampli¢cation of each
DNA template in the multiplex-PCR is crucial for library-
size expansion. In principle, ampli¢cation by PCR occurs in
a non-linear manner. When the starting number of each tem-
plate in a PCR reaction is imbalanced, the quantitative rela-
tionship among each kind of DNA in the PCR product is
generally not the same as their relation before the ampli¢ca-
tion. However, in our multiplex-PCR where total number of
DNA template is relatively very small and the starting number
of every DNA template is equal (i.e. one molecule each), and
with the use of a single primer that can e¡ectively prevent by-
product formation [9,13] the ampli¢cation of every DNA tem-
plate is expected to be equivalent. In order to investigate the
equality of ampli¢cation of every DNA template, considering
the number of sequencing works, we chose ¢ve-molecule PCR
as a representative of the multiplex-PCR to be studied on an
assumption that the PCR of a greater number of templates
will behave correspondingly. Five-molecule PCRs of anti-
Fig. 1. Schematic representation of SIMPLEX-based protein library construction and screening. 1: DNA templates in the gene pool are diluted
to a speci¢ed number of molecules per well and ampli¢ed by the multiplex-PCR yielding the primary PCR library. 2: The PCR library is con-
verted to the primary protein library by means of cell-free protein synthesis. 3: The protein library is screened for clones with desired proper-
ties. 4: DNAs encoding for positive clones are collected, and prepared for the second round of screening where the SM-PCR is performed in-
stead of the multiplex-PCR in order to isolate single genes (5^7).
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HSA-scFv genes with random mutation in its light chain at
G99 and A100 (NNS NNS) were performed. Each of ¢ve
PCR products was cloned and transformed. Colonies were
picked randomly and their sequences at the randomized sites
were analyzed. Results are shown in Table 1. Kinds of ob-
served sequences represent numbers of templates in each ¢ve-
molecule PCR reaction and number of clones possessing each
sequence represents its molecular ratio in the PCR product.
From each ¢ve-molecule PCR product, an approximately
equivalent number of each sequence was observed demon-
strating an equal ampli¢cation of each template in the reac-
tion. Divergence of all sequences observed indicates diversity
of the PCR library. When PCRs from ¢ve molecules on aver-
age were performed, more or less numbers of templates were
predictably observed in some reactions owing to the stochastic
dilution.
3.3. Library of anti-HSA-scFv with random mutation
Since there are multiple proteins in one well in the primary
protein library, a detected signal in the ¢rst screening process
is an accumulative value of those molecules. Hence, it is not
suitable for a comparative screening for an improvement in
some properties of proteins. On the other hand, the strategy is
extremely useful for an on^o¡ screening or a screening for
new targets. In one of our preliminary experiments, we no-
ticed that binding a⁄nity of the anti-HSA-scFv decreased
dramatically when Q90 and W91 of the light chain were ran-
domly mutagenized (data not shown). We thought that one or
both of these amino acid residues might be conserved and
therefore a library of the anti-HSA-scFv with random muta-
tion at Q90 and W91 was a good example for an on^o¡
screening.
In order to demonstrate a widen application of the strategy,
we constructed and screened the library [Lib. anti-HSA-
scFv(QW)] aiming at obtaining a clone that has the same
sequence with the wild type. With NNS NNS mutation, there
were 961 variants in the library. The library was initially gen-
erated by 10-molecule PCRs in two 96-well plates, and sub-
sequently transformed to a protein library in the same plate
format. After the ¢rst screening by ELISA, nine PCR prod-
ucts (average of 90 variants) were selected, mixed and puri¢ed.
SM-PCRs of selected PCR products were carried out in three
96-well plates. The PCR library was converted to a protein
library and screened in the same manner with the ¢rst round.
Sequences of positive variants were analyzed and the results
are shown in Table 2. The clone X1A, which shows the high-
est ELISA signal, has the sequence at the mutation site iden-
tical to the wild type as we have anticipated.
4. Discussion
We have developed a new strategy for high-throughput
construction and screening of combinatorial protein libraries
based on the SIMPLEX. The uniformities of amounts of both
PCR products and proteins produced by the SIMPLEX,
which are critical for comparative screening, were previously
con¢rmed [14]. In this work, we have expanded the achievable
size of the SIMPLEX-based library by employing the multi-
plex-PCR. Equality of ampli¢cation of every template in the
multiplex-PCR that is vital for library size expansion was val-
idated. Regarding the NNS NNS randomization where S rep-
resents C or G, there were unexpected As or Ts at the sixth
nucleotide of a few observed sequences as the results show in
Table 1. We examined £anking sequences of the mutation site
and did not observe any spontaneous mutation. Spontaneous
mutation rate of the SM-PCR, which is performed in a nearly
identical condition with the multiplex-PCR, was reported to
Fig. 2. Design of the DNA templates for experiments. A: Schematic
representation of the DNA template ready for ampli¢cation by
PCR and in vitro coupled transcription/translation. It contains a
DNA tag (tag) serving as primer annealing sites at both ends, T7
promoter (T7P), ribosome binding site (RBS), anti-HSA-scFv en-
coding gene (AlbscFv), and T7 terminator (T7T). B: The sequence
at the mutation site (underline) in the VH of the DNA templates
that were used in the investigation of equality of ampli¢cation in
the multiplex-PCR. C: The sequence at the mutation site (underline)
in the VL of the library anti-HSA-scFv(QW).
Table 1
Equality of ampli¢cation of each anti-HSA-scFv mutant in ¢ve-mol-
ecule PCR
PCR product number Nucleotide sequence Number of clones
1 TCC GCC 7
CGC TCA 7
ATC ACA 6
2 TAC GAC 5
GTC GCT 4
GGC GAC 6
ATC AGC 4
CCG TTC 5
3 TGC ACG 5
TAC ACG 4
TGG CAC 2
TGC GCG 5
CCC ACC 5
4 TTC GTC 4
CCG GTC 5
TGC ACC 4
TCC TCA 4
CAG AAG 4
ATC ACG 4
5 CCC GCC 4
ACC TTC 4
CAG GCC 3
TAC CAC 3
AGC CTG 3
ATG ACC 3
The observed sequences at the randomized site and the numbers of
clones that possessed the same sequence are shown. Sequence of the
wild type is GGG GCT.
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be very low [13]. Thus, the disagreement is likely due to poor
quality of primers that were used to introduce the random
sequences.
By a typical dilution, although number of templates in some
PCR reactions may be more or less, the average number of
templates per reaction is ¢ve. Accordingly, an achievable size
of the library generated by multiplex-PCR will be presumably
enlarged X times, as the number of templates in the initial
multiplex-PCR is X. Considering the e⁄ciency of the SM-
PCR, although the template concentration is precise and am-
pli¢cation of one molecule is 100% e⁄cient, only 63% of all
reactions will be successfully ampli¢ed according to the Pois-
son distribution, and the other 36% is wasted [14]. As the
initial construction, the use of multiplex-PCR where nearly
100% of reaction is e¡ective will substantially increase not
only the library size but also the cost^e¡ectiveness.
Generally, the e⁄ciency of ampli¢cation by each DNA
polymerase depends on sequences of templates and primers.
In our system, every template has the same primer annealing
site. For a library that the di¡erence among templates is rel-
atively small such as a mutant library or a naive scFv library,
ampli¢cation of every template in the multiplex-PCR should
be balance. However, for a general gene library such as cDNA
in which the divergence of sequence may be large, the ampli-
¢cation will be bias, a¡ecting the correlation between the
number of templates in the multiplex-PCR and the achievable
library size. In spite of this, the use of multiplex-PCR is still
helpful for the capacity expansion.
In the SM-PCR, amounts of PCR products are uniform
because every reaction reaches a plateau stage even though
some might be ampli¢ed from multiple molecules [14,16]. As
number of genes in the multiplex-PCR increases, amount of
each gene in the PCR product decreases, consequently reduc-
ing amount of each protein produced in the subsequent step.
Therefore, sensitivity of the screening method and the number
of molecules in the initial multiplex-PCR must be carefully
optimized before construction of the library.
In conclusion, our system has a number of appealing char-
acteristics. It is performed entirely in vitro and the protein
generation is highly parallel. The genotype^phenotype linkage
is through the position of wells on plates, which is easy to
maintain. DNA is more stable than RNA which is used in
other in vitro systems. As numerous copies of a gene (V50
ng/Wl of a PCR product) are used as the template for the in
vitro expression, a large amount of each protein is produced
which enhances the sensitivity of detection. The library can be
screened by not only a⁄nity selection but also enzymatic ac-
tivity. Signi¢cantly, it is speedy and completely suits automa-
tion. With a precise liquid handling system and an array tech-
nology [17^20], this strategy could be a powerful tool for
high-throughput construction and screening of various pro-
tein libraries.
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Table 2
Nucleotide and amino acid sequences at the mutation site and ELISA signals (absorbance at 492 nm) of the positive clones from the Lib. anti-
HSA-scFv(QW) after the secondary screening
Clone name Nucleotide sequence Amino acid sequence ELISA signal
Ctrl WT CAG TGG Q W 0.510
X1A CAG TGG Q W 0.529
Z6A TAC TGG Y W 0.479
Z7G TAC TGG Y W 0.472
X2C CTC ATG L M 0.375
Z1B TCG GTC S V 0.303
X3D AGC ATC S I 0.281
X3F CTG ACC L T 0.235
X4A TGC GTC C V 0.200
Z1C ATC TCC I S 0.129
X3H TGC AGC C S 0.123
Z1G ACC GTG T V 0.107
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